Cargando…
A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal
BACKGROUND: Generalized anxiety disorder is characterized by excessive anxiety and worry about several events and activities. The estimated 1-year prevalence for adults is around 2% and the lifetime prevalence could reach more than 6%. The disease is associated with reduced quality of life, being co...
Autores principales: | Silva Miguel, Luís, Silva Miguel, Nuno, Inês, Mónica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637226/ https://www.ncbi.nlm.nih.gov/pubmed/23587174 http://dx.doi.org/10.1186/1478-7547-11-8 |
Ejemplares similares
-
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
por: Vera-Llonch, Montserrat, et al.
Publicado: (2009) -
Venlafaxine extended release (XR) in the treatment of panic disorder
por: Kjernisted, Kevin, et al.
Publicado: (2007) -
Pregabalin for the treatment of generalized anxiety disorder
por: Khallouk, A., et al.
Publicado: (2022) -
Pharmacoeconomic evaluation of venlafaxine compared with citalopram in generalized anxiety disorder
por: ZHANG, JINGJING, et al.
Publicado: (2013) -
Role of pregabalin in the treatment of generalized anxiety disorder
por: Baldwin, David S, et al.
Publicado: (2007)